From today (8th), the quarantine authorities will administer Evusheld, an antibody injection for prevention, for severely immunocompromised patients. The COVID-19 Vaccination Response Promotion Team (Director Baek Kyung-ran) announced today (the 8th) that it will start taking Evuseld to prevent COVID-19 among immunocompromised people. Evuseld is a preventive antibody injection that directly injects antibodies into the body to cause preventive effects to those who are unable to form immunity due to immunosuppressive treatment and severe immunodeficiency symptoms.

Evuseld was introduced in Korea under the approval of the MFDS. As a result of clinical trials, preventive effects were confirmed, such as 93%